Titre : Composés benzyliques

Composés benzyliques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Sleep Initiation and Maintenance Disorders
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Composés benzyliques : Questions médicales les plus fréquentes", "headline": "Composés benzyliques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Composés benzyliques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-26", "dateModified": "2025-02-20", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Composés benzyliques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dérivés du benzène", "url": "https://questionsmedicales.fr/mesh/D001555", "about": { "@type": "MedicalCondition", "name": "Dérivés du benzène", "code": { "@type": "MedicalCode", "code": "D001555", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Alcools benzyliques", "alternateName": "Benzyl Alcohols", "url": "https://questionsmedicales.fr/mesh/D001592", "about": { "@type": "MedicalCondition", "name": "Alcools benzyliques", "code": { "@type": "MedicalCode", "code": "D001592", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.140.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Alcool benzylique", "alternateName": "Benzyl Alcohol", "url": "https://questionsmedicales.fr/mesh/D019905", "about": { "@type": "MedicalCondition", "name": "Alcool benzylique", "code": { "@type": "MedicalCode", "code": "D019905", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.140.200.100" } } } ] }, { "@type": "MedicalWebPage", "name": "Benzylamines", "alternateName": "Benzylamines", "url": "https://questionsmedicales.fr/mesh/D001596", "about": { "@type": "MedicalCondition", "name": "Benzylamines", "code": { "@type": "MedicalCode", "code": "D001596", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.140.210" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Pargyline", "alternateName": "Pargyline", "url": "https://questionsmedicales.fr/mesh/D010293", "about": { "@type": "MedicalCondition", "name": "Pargyline", "code": { "@type": "MedicalCode", "code": "D010293", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.140.210.650" } } } ] }, { "@type": "MedicalWebPage", "name": "Bibenzyles", "alternateName": "Bibenzyls", "url": "https://questionsmedicales.fr/mesh/D001632", "about": { "@type": "MedicalCondition", "name": "Bibenzyles", "code": { "@type": "MedicalCode", "code": "D001632", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.140.308" } } }, { "@type": "MedicalWebPage", "name": "Lignanes", "alternateName": "Lignans", "url": "https://questionsmedicales.fr/mesh/D017705", "about": { "@type": "MedicalCondition", "name": "Lignanes", "code": { "@type": "MedicalCode", "code": "D017705", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.140.450" } } } ], "about": { "@type": "MedicalCondition", "name": "Composés benzyliques", "alternateName": "Benzyl Compounds", "code": { "@type": "MedicalCode", "code": "D001593", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Alexander P Atkins", "url": "https://questionsmedicales.fr/author/Alexander%20P%20Atkins", "affiliation": { "@type": "Organization", "name": "University of Bristol, School of Chemistry, Bristol, BS8 1TS, U.K." } }, { "@type": "Person", "name": "Alastair J J Lennox", "url": "https://questionsmedicales.fr/author/Alastair%20J%20J%20Lennox", "affiliation": { "@type": "Organization", "name": "University of Bristol, School of Chemistry, Bristol, BS8 1TS, U.K." } }, { "@type": "Person", "name": "Hiroaki Tsuji", "url": "https://questionsmedicales.fr/author/Hiroaki%20Tsuji", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Humanities & Sciences, Nihon University, Sakurajosui, Setagaya-ku, Tokyo 156-8550, Japan. tsuji@chs.nihon-u.ac.jp kawatsur@chs.nihon-u.ac.jp." } }, { "@type": "Person", "name": "Motoi Kawatsura", "url": "https://questionsmedicales.fr/author/Motoi%20Kawatsura", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Humanities & Sciences, Nihon University, Sakurajosui, Setagaya-ku, Tokyo 156-8550, Japan. tsuji@chs.nihon-u.ac.jp kawatsur@chs.nihon-u.ac.jp." } }, { "@type": "Person", "name": "Yan-Hong He", "url": "https://questionsmedicales.fr/author/Yan-Hong%20He", "affiliation": { "@type": "Organization", "name": "Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Knowledge, attitude, and practice toward sleep disorders and sleep hygiene among perimenopausal women.", "datePublished": "2024-05-22", "url": "https://questionsmedicales.fr/article/38777871", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-62502-4" } }, { "@type": "ScholarlyArticle", "name": "Sleep Disturbances in Children with Attentional Deficit Hyperactivity Disorder and Specific Learning Disorders.", "datePublished": "2022-05-25", "url": "https://questionsmedicales.fr/article/35681996", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph19116411" } }, { "@type": "ScholarlyArticle", "name": "Impact of sleep disorders and disease duration on neurotrophins levels in cocaine use disorder.", "datePublished": "2022-07-16", "url": "https://questionsmedicales.fr/article/35850320", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neulet.2022.136805" } }, { "@type": "ScholarlyArticle", "name": "Sex differences in the effects of sleep disorders on cognitive dysfunction.", "datePublished": "2023-01-27", "url": "https://questionsmedicales.fr/article/36716906", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neubiorev.2023.105067" } }, { "@type": "ScholarlyArticle", "name": "Occupational Exposure to Pesticides as a Risk Factor for Sleep Disorders.", "datePublished": "2023-02-10", "url": "https://questionsmedicales.fr/article/36833840", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20043149" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Composés benzyliques", "item": "https://questionsmedicales.fr/mesh/D001593" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Composés benzyliques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Composés benzyliques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Composés benzyliques", "description": "Comment diagnostiquer une exposition aux composés benzyliques ?\nQuels tests sont utilisés pour détecter les composés benzyliques ?\nQuels symptômes indiquent une intoxication aux composés benzyliques ?\nY a-t-il des marqueurs biologiques pour les composés benzyliques ?\nComment évaluer le risque d'exposition aux composés benzyliques ?", "url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Composés benzyliques", "description": "Quels sont les symptômes courants d'une exposition aux composés benzyliques ?\nLes composés benzyliques provoquent-ils des allergies ?\nQuels effets à long terme peuvent résulter d'une exposition ?\nLes symptômes varient-ils selon le type de composé ?\nComment les symptômes se manifestent-ils chez les enfants ?", "url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Composés benzyliques", "description": "Comment prévenir l'exposition aux composés benzyliques ?\nY a-t-il des réglementations pour l'utilisation de ces composés ?\nQuels conseils donner aux travailleurs exposés ?\nLes entreprises doivent-elles effectuer des évaluations de risque ?\nComment sensibiliser le public aux dangers des composés benzyliques ?", "url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Composés benzyliques", "description": "Quel traitement est recommandé en cas d'intoxication ?\nDes antidotes existent-ils pour les composés benzyliques ?\nComment traiter les irritations cutanées causées par ces composés ?\nLes traitements varient-ils selon l'âge du patient ?\nQuels soins d'urgence sont nécessaires en cas d'exposition aiguë ?", "url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Composés benzyliques", "description": "Quelles complications peuvent survenir après une exposition prolongée ?\nLes composés benzyliques peuvent-ils causer des cancers ?\nComment les complications sont-elles gérées ?\nLes complications varient-elles selon le type de composé ?\nQuels sont les effets à long terme sur la santé ?", "url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Composés benzyliques", "description": "Quels sont les principaux facteurs de risque d'exposition ?\nLes enfants sont-ils plus à risque d'exposition ?\nComment le mode de vie influence-t-il le risque d'exposition ?\nLes travailleurs de la santé sont-ils à risque ?\nQuels environnements présentent un risque accru ?", "url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une exposition aux composés benzyliques ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les composés benzyliques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication aux composés benzyliques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des nausées et des irritations cutanées." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs biologiques pour les composés benzyliques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des métabolites spécifiques peuvent être mesurés dans les fluides corporels." } }, { "@type": "Question", "name": "Comment évaluer le risque d'exposition aux composés benzyliques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation des conditions de travail et des habitudes de vie est nécessaire." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une exposition aux composés benzyliques ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des irritations cutanées, des maux de tête et des vertiges." } }, { "@type": "Question", "name": "Les composés benzyliques provoquent-ils des allergies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent développer des réactions allergiques aux composés benzyliques." } }, { "@type": "Question", "name": "Quels effets à long terme peuvent résulter d'une exposition ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut entraîner des troubles neurologiques et des problèmes respiratoires." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de composé ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de la structure chimique et de la dose." } }, { "@type": "Question", "name": "Comment les symptômes se manifestent-ils chez les enfants ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent présenter des symptômes plus graves, comme des troubles du comportement." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux composés benzyliques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité." } }, { "@type": "Question", "name": "Y a-t-il des réglementations pour l'utilisation de ces composés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réglementations strictes encadrent leur utilisation dans l'industrie et la recherche." } }, { "@type": "Question", "name": "Quels conseils donner aux travailleurs exposés ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Suivre les formations de sécurité et signaler toute exposition suspecte immédiatement." } }, { "@type": "Question", "name": "Les entreprises doivent-elles effectuer des évaluations de risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les entreprises doivent régulièrement évaluer les risques liés à l'exposition." } }, { "@type": "Question", "name": "Comment sensibiliser le public aux dangers des composés benzyliques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Organiser des campagnes d'information et des formations sur les risques associés." } }, { "@type": "Question", "name": "Quel traitement est recommandé en cas d'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement comprend l'élimination de l'exposition et des soins symptomatiques." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les composés benzyliques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique." } }, { "@type": "Question", "name": "Comment traiter les irritations cutanées causées par ces composés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des crèmes apaisantes et éviter tout contact avec le composé irritant." } }, { "@type": "Question", "name": "Les traitements varient-ils selon l'âge du patient ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction de l'âge et de la santé générale." } }, { "@type": "Question", "name": "Quels soins d'urgence sont nécessaires en cas d'exposition aiguë ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les soins d'urgence incluent le lavage des zones exposées et l'administration d'oxygène si nécessaire." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une exposition prolongée ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des troubles respiratoires et des effets neurologiques peuvent survenir." } }, { "@type": "Question", "name": "Les composés benzyliques peuvent-ils causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien potentiel entre l'exposition prolongée et certains cancers." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite un suivi médical régulier et des traitements adaptés." } }, { "@type": "Question", "name": "Les complications varient-elles selon le type de composé ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent varier en fonction de la structure chimique et de la dose." } }, { "@type": "Question", "name": "Quels sont les effets à long terme sur la santé ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les effets à long terme peuvent inclure des troubles neurologiques et des problèmes respiratoires." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'exposition ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent le travail dans l'industrie chimique et l'utilisation domestique." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque d'exposition ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants sont plus vulnérables en raison de leur comportement exploratoire." } }, { "@type": "Question", "name": "Comment le mode de vie influence-t-il le risque d'exposition ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie impliquant l'utilisation de produits chimiques augmente le risque d'exposition." } }, { "@type": "Question", "name": "Les travailleurs de la santé sont-ils à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les travailleurs de la santé peuvent être exposés lors de l'utilisation de certains médicaments." } }, { "@type": "Question", "name": "Quels environnements présentent un risque accru ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les environnements industriels et de laboratoire présentent un risque accru d'exposition." } } ] } ] }

Sources (10000 au total)

Impact of sleep disorders and disease duration on neurotrophins levels in cocaine use disorder.

Brain-derived neurotrophic factor (BDNF) and its precursor proBDNF contribute to brain plasticity and neuronal remodeling. Recently, the ratio between proBDNF and BDNF (RpB) has been proposed as a pos... Subjects with a moderate to severe CUD were recruited. ProBDNF, BDNF and consequently RpB values were analyzed using ELISA technique. Insomnia severity index (ISI) scale was used to assess the severit... Twenty-four subjects (mean age 39.3 ± 6.7 years) were recruited. Correlation analysis showed that lower values of RpB were associated with higher ISI score (r = -0.469; p = 0.021), longer history of c... These preliminary findings may offer a novel insight on neurobiological alterations sustaining cocaine use. Lower RpB, as observed both in high insomnia levels and in chronic cocaine use, could induce...

Relating parental stress with sleep disorders in parents and children.

To assess whether child sleep disorders positively correlate with parental insomnia, hypersomnia, and sleep apnea, and whether parental and child sleep disorders simultaneously positively associate wi... Analyses are based on 14,009 employees aged 18-64 with dependent children (n = 44,157) insured by Deseret Mutual Benefit Administrator (DMBA) in 2020. Rate ratios are adjusted for age, sex, and marita... The rate of parental stress is 3.00 (95% CI 2.33-4.85) times greater for those with insomnia and 1.88 (95% CI 1.59-2.22) times greater for those with sleep apnea. There is no increased risk of stress ... Better understanding the connection between parent and child sleep problems and parent stress, and modifying influences, may improve treatment of these disorders....

Sleep Symptoms and Disorders in Episodic Migraine: Assessment and Management.

We review research on sleep symptoms and disorders in patients with episodic migraine and propose a framework for evaluating sleep symptoms in this patient population.... Patients with episodic migraine consistently report poorer sleep on validated self-reports compared to those without migraine. In polysomnographic studies, children with migraine have objectively shor...

Distinct phenotypic clusters of sleep-disordered breathing and their association with medical care-seeking behaviour and sleep habits: the Guangdong Sleep Health Study.

Sleep-disordered breathing (SDB) is highly prevalent, but its rates of diagnosis and treatment are low. As a heterogeneous condition, it is associated with delayed diagnosis and/or suboptimal treatmen...